← Eichor
Study identifier: NCT07004140 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients

Condition: Stroke Acute  ·  Sponsor: University of Aberdeen

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can show changes in the brain within the first day of a stroke due to a blocked blood vessel or bleeding in the brain. The main question it aims to answer is: • Can FCI identify brain tissue that might recover within the first few hours after a stroke begins? Participants will undergo a standard MRI scan and an FCI scan, as soon as possible after hospital admission. Participants who have had a blocked blood vessel will also provide a blood sample and will have a follow up visit at 30 days for repeat of both scans and providing another blood sample.

This description comes directly from the study's public registry record.

Talk to the study team

Mary Joan MacLeod, PhD  ·  +44 1224 437842  ·  m.j.macleod@abdn.ac.uk

Gordon D Waiter, PhD  ·  +44 1224 438356  ·  g.waiter@abdn.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

University of AberdeenAberdeen, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07004140